glp-1 gastric intestinal obstruction lawsuit in michigan Severe Small-Bowel a High-Risk Patient on Long-Term Tirzepatide Therapy: A Case Report michigan glp-1 gastric intestinal obstruction

Dean Jones: Website: YouTube: 41m - Dec 16, 2025 Eat Like a GLP-1 Super Responder (with Erin Palinski-Wade) Welcome back to The Holistic GLP-1 Podcast where we elevate your GLP-1 journey and your whole life: body, mind, and soul

Significant reduction in body weight and appetite

Tirzepatide causes thyroid C-cell tumors in rats, and although its unknown whether tirzepatide causes thyroid C-cell tumors in humans, it is contraindicated in patients with a personal or family history of MTC or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

The once-weekly dosing is also more convenient than daily oral medications for many patients

The British Menopause Society recommends switching to non-oral formulations as the most reliable option for managing menopause symptoms